Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach
Authors
Keywords
-
Journal
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Volume -, Issue -, Pages 173523
Publisher
Elsevier BV
Online
2023-01-30
DOI
10.1016/j.pbb.2023.173523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
- (2022) Ellen Scotton et al. BIOCHEMICAL PHARMACOLOGY
- Brain Structural and Functional Changes in Cognitive Impairment Due to Alzheimer’s Disease
- (2022) Marina Ávila-Villanueva et al. Frontiers in Psychology
- Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
- (2021) Wei Yao et al. MOLECULAR PSYCHIATRY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
- (2020) Kai Zhang et al. Translational Psychiatry
- The Role of BDNF on Neural Plasticity in Depression
- (2020) Tao Yang et al. Frontiers in Cellular Neuroscience
- Shared genetic etiology underlying Alzheimer’s disease and major depressive disorder
- (2020) Michael W. Lutz et al. Translational Psychiatry
- The ERK Pathway: Molecular Mechanisms and Treatment of Depression
- (2019) John Q. Wang et al. MOLECULAR NEUROBIOLOGY
- g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
- (2019) Uku Raudvere et al. NUCLEIC ACIDS RESEARCH
- Amyloid Beta and MicroRNAs in Alzheimer’s Disease
- (2019) Nnana Amakiri et al. Frontiers in Neuroscience
- PSD-95 deficiency disrupts PFC-associated function and behavior during neurodevelopment
- (2019) Austin A. Coley et al. Scientific Reports
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Silencing of TGFβ signalling in microglia results in impaired homeostasis
- (2018) Tanja Zöller et al. Nature Communications
- Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data
- (2018) Nadezhda T. Doncheva et al. JOURNAL OF PROTEOME RESEARCH
- Depression
- (2018) Gin S Malhi et al. LANCET
- TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson’s Disease
- (2017) Xiao Chen et al. Journal of Neuroimmune Pharmacology
- Further Investigation of Ketamine
- (2016) Robert Freedman AMERICAN JOURNAL OF PSYCHIATRY
- WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?
- (2016) D. Jeffrey Newport et al. DEPRESSION AND ANXIETY
- Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
- (2016) Danielle M. Gerhard et al. DRUG DISCOVERY TODAY
- TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage
- (2016) Roslyn A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Bone density and depressive disorder: a meta-analysis
- (2016) Julietta Ursula Schweiger et al. Brain and Behavior
- Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
- (2015) Kenji Hashimoto INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density
- (2015) Xiaobing Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Optimizing the management of depression: primary care experience
- (2014) Catherine Cameron et al. PSYCHIATRY RESEARCH
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Ketamine for Treatment-Resistant Unipolar Depression
- (2012) Sanjay J. Mathew et al. CNS DRUGS
- Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro
- (2012) Björn Spittau et al. GLIA
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection
- (2011) Filippo Caraci et al. CELL AND TISSUE RESEARCH
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now